Maxwell Biosciences Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $3.7M
Latest Deal Amount
  • Investors
  • 21

Maxwell Biosciences General Information

Description

Developer of a novel synthetic biomimic drug class intended to target human virus. The company's virucidal drugs mimic natural antimicrobial peptides and destroy a broad range of viruses directly, irreversibly and permanently inactivating the virus itself. Maxwell drug candidates have direct virucidal action against SARS-CoV-2, the COVID-19 virus. Maxwell's drugs have undergone testing and is effective against Herpes Simplex Virus-1 (HSV-1), Chikungunya, Hepatitis B Virus (HBV ), and Influenza.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 3809 Juniper Trace
  • Suite 102
  • Austin, TX 78738
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Maxwell Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 01-Oct-2020 $3.7M 00.00 Completed Pre-Clinical Trials
1. Grant 0000 Completed Pre-Clinical Trials
To view Maxwell Biosciences’s complete valuation and funding history, request access »

Maxwell Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a novel synthetic biomimic drug class intended to target human virus. The company's virucidal drugs mimic n
Drug Discovery
Austin, TX
9 As of 2020
00.00
000000000 00.00

0000000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
000000000 0000000000
Luçon, France
0 As of 0000
00000
000000 - 000 00000

00000000

tetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
000000000000000
Saint-Amand-Les-Eaux, France
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Maxwell Biosciences Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Moderna Venture Capital-Backed Luçon, France 0 00000 000000 - 000 00000
000000000000000 00 Corporation Saint-Amand-Les-Eaux, France
You’re viewing 2 of 2 competitors. Get the full list »

Maxwell Biosciences Executive Team (5)

Name Title Board Seat Contact Info
Joshua McClure Co-Founder, Co-Inventor, Chief Executive Officer & Board Member
Mark Pomeroy Chief Operating Officer
Kent Kirshenbaum Ph.D Chief Scientific Officer
Annelise Barron Ph.D Co-Founder, Co-Inventor & Board Member
You’re viewing 4 of 5 executive team members. Get the full list »

Maxwell Biosciences Board Members (4)

Name Representing Role Since
Annelise Barron Ph.D Maxwell Biosciences Co-Founder, Co-Inventor & Board Member 000 0000
Joshua McClure Maxwell Biosciences Co-Founder, Co-Inventor, Chief Executive Officer & Board Member 000 0000
Robert Neville Self Board Member 000 0000
Stephen Pearse Yucatan Rock Ventures Executive Chairman 000 0000
To view Maxwell Biosciences’s complete board members history, request access »

Maxwell Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Maxwell Biosciences Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3Rodeo Venture Capital Minority 000 0000 000000 0
Brazos Resources, LP Growth/Expansion Minority 000 0000 000000 0
Campa Investments Other Minority 000 0000 000000 0
Capital Factory Venture Capital Minority 000 0000 000000 0
Catanzaro Family Other Minority 000 0000 000000 0
You’re viewing 5 of 21 investors. Get the full list »